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General methods
Unless otherwise noted, all reagents including anhydrous solvents were obtained from commercial suppliers and used as delivered without further purification. Alkanethiol linkers [HS-(CH 2 ) 17 -(OC 2 H 4 ) 3 -OH and HS-(CH 2 ) 17 -(OC 2 H 4 ) 6 -OCH 2 COOH] were purchased from Prochimia Surfaces (Poland). The peptide CQDSETRTFY 9 was purchased from Bachem (UK). Reverse phase HPLC was performed on Agilent 1100 and Agilent 1200 systems using Phenomenex Luna 5 µm, 250 x 150 mm semi-preparative C18 column with UV detection at 210 nm. Unless otherwise stated all MALDI-ToF MS experiments were carried out on an Ultraflex II instrument (Bruker Daltonics) in positive reflectron mode. A solution of matrix (2,4,6-trihydroxyacetophenone, 10 mg/mL in acetone) was applied on the gold and allowed to dry before analysis. All spectra were analysed with FlexAnalysis software (Bruker, USA) using default integration settings. Calibration was either performed before the analysis at the Ultraflex II instrument or afterwards in FlexAnalysis. Unless otherwise noted, all m/z values refer to the [M+Na] + ion and the corresponding disulphide which is formed during ionisation.
Reactions were monitored by thin-layer chromatography using either silica gel 60 GF254 on aluminium foil (Merck) or RP-18 F254s on aluminium foil (Merck) with detection by UV light and charring with sulfuric acid in EtOH (10 %). Silica gel 60 Å (Merck, 230-400 mesh) was used for flash chromatography. Preparative MPLC was performed on a Büchi apparatus using a LiChroprep RP-18 (40-60 mm, Merck) column for reverse phase and a LiChroprep Si 60 (40-60 mm, Merck) column for normal phase silica gel chromatography. Size exclusion chromatography (SEC) was carried out on Sephadex LH-20 from PharmaciaBiotech. 1 H and 13 C NMR spectra were recorded using a Bruker DRX-500 or a Bruker AV-600 spectrometer. NMR spectra were calibrated with respect to the solvent peak (in case of CDCl 3 the reference was tetramethylsilane (TMS)). 2D NMR techniques (COSY, HSQC, HMBC) were used for full assignment of the spectra. ESI MS measurements were performed on a Mariner ESI-ToF 5280 instrument (Applied Biosystems). High-resolution mass spectra (HR-ESI MS) were obtained with the Waters Micromass LCT TOF mass spectrometer. MALDI-ToF mass spectra were recorded on a Bruker Biflex-III 19 kV instrument with Cl-CCA (4-chloro-α-cyanocinnamic acid) or DHB (2,5-dihydroxybenzoic acid) as matrix. Optical rotations were measured on a Perkin-Elmer polarimeter 341 (Na-D-line: 589 nm, length of cell 1 dm). IR spectra were recorded on a Perkin-Elmer Paragon 1000 FT-IR spectrometer. For sample preparation a Golden Gate-diamond-ATR unit with a saphire stamp was used. Melting points were measured on a MPD 350 (Fa. Gallenkamp) apparatus. : = 2976, 1722, 1657, 1525, 1449, 1366, 1316, 1231, 1146, 1099, 1043, 953, 849, 801, 760, 739 cm -1 .
S 6 2960, 1726, 1701, 1638, 1537, 1450, 1410, 1295, 1236, 1175, 1157, 1102, 1045, 931, 738 cm -1 . : = 3286, 2927, 2885, 1638, 1542, 1449, 1243, 1175, 1157, 1131, 1052, 804, 739 cm -1 .
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3-Cascade:N-(tert-butyloxycarbonyl)-S-(triphenylmethyl)-L-cysteinyl-glycyl-aminomethane[3]:4-oxo-3-aza-hexyl-α-D-mannopyranoside (22)
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Method for Native Chemical Ligation (NCL) of N-terminal Cys-peptides (9, 11) and -carbohydrates (13, 23)
Unless otherwise stated, an aqueous buffer containing 5 M Guanidine (Gn·HCl), 75 mM Na 2 HPO 4 , 20% MeCN, and 2.5 M imidazole HCl (for reactions in absence of imidazole, no imidazole HCl and MeCN was used) was premixed and the pH was adjusted to 7 using 5 M NaOH. Cysteine-derivatives (9, 11, 13, 23) and/or amino-derivatives (10, 12, 14, 15, 21) with TCEP (7.5 eq. relative to Cys-derivative; reactions of only the amino-derivative were carried out without TCEP) were added in various concentrations. Reactions were carried out overnight and were directly analysed. 
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Surface Plasmon Resonance (SPR) Analysis
The experiments were performed on a Biacore 3000 system (GE Healthcare, Sweden) using Sensor Chip Au (GE Healthcare). The gold coated sensor was cleaned with piranha solution, rinsed with water, ethanol and dried in a stream of nitrogen. The formation of self-assembling monolayers was performed in the same way as described (see above). The chip was washed with ethanol, dried under nitrogen and mounted into a chip holder following instructions in the supplier's manual. After docking in the instrument the sensor was equilibrated with phosphate buffer saline (PBS, degassed and filtered) at a flow rate of 10 L/min. For surface activation, 70 l of a 1:1 mixture of freshly prepared NHS (0.4 M) and EDC (0.1 M) in water were injected (Channels 1-3). Reference spot (channel 1) was blocked by injecting 70 l of amino ethanol HCl (1 M). Aminoethyl GlcNAc 14 (10 mM, Channel 2) and mannosylcysteine 13 (2 mM and 15 mM TCEP, Channel 3) were immobilised by injecting 100 l of the substrate solution in PBS followed by blocking with amino ethanol (70 l, 1 M). The SAMs in channel 4 were PFP-activation. In order to perform this activation the chip was undocked, and the gold surface coated with 2 L of EDC and PFP (final concentrations 0.180 M and 0.174 M, respectively) in dry DMF at r.t. After 30 min the chip was washed with ethanol, and dried under nitrogen. After docking of the chip, the SPR chip was equilibrated with PBS buffer at a flow rate of 5 L/min and 250 L of the reaction mixture of 2 mM GlcNAc-NH 2 14 and 2 mM Cys-Man 13 under NCL conditions (see section 4) were injected within an hour (channel 4).
Binding studies were carried out using HEPES buffer (10 mM HEPES, 0.15 M NaCl, 1 mM CaCl 2 , 1 mM MnCl 2 , pH 7.4) at a flow rate of 25 l/min. 250 l of lectin solution (50 g/mL) were injected followed by 600 s dissociation sequence. The chip surface was regenerated by injecting 200 l of 100 mM glycine-HCl solution (pH 2).
Figure S36
The cysteine compound Cys-Man 13 and the amino-compound GlcNAc 14 were applied in a competitive assay at 2 mM on PFP activated SAMs.
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Figure S37 SPR analysis of the reaction in Figure S36 shown in Channel 4. Black: immobilised GlcNAc 14, Red: immobilised Cys-Man 13. a) Readout with the mannose binding lectin concanavalin A (ConA) (50 g/mL). ConA showed strong binding to the spot (blue) were the competitive reaction was carried out. This shows the presence of the Cys-Man 13. b) Readout with the GlcNAc binding lectin wheat germ agglutinin (WGA) (50 g/mL) showed no binding to the spot (blue) were the competitive reaction was carried out. This shows that no GlcNAc 14 has bound to the surface.
a) b)
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